ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 1107

$1.43M Total Retail Price of All Prescriptions

Rank: 31 out of 1107

665 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 665 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 665 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 15,255 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,019 610 S3 1 1
OMEPRAZOLE 814 478 2 4
LISINOPRIL 759 505 3 2
LEVOTHYROXINE SODIUM 713 444 4 3
AMLODIPINE BESYLATE 645 478 5 6
FUROSEMIDE 638 459 6 7
SIMVASTATIN 491 303 7 5
CARVEDILOL 443 327 8 27
TRAMADOL HCL 419 275 9 26
GABAPENTIN 371 267 10 9
HYDROCHLOROTHIAZIDE 361 297 11 11
METFORMIN HCL 355 172 12 8
ATENOLOL 307 223 13 19
CITALOPRAM HBR 307 170 13 17
PROMETHAZINE HCL 278 95 R 15 44
MELOXICAM 268 182 16 25
TRAZODONE HCL 249 152 17 33
PANTOPRAZOLE SODIUM 235 162 18 30
POTASSIUM CHLORIDE 223 171 19 14
NOVOLOG 202 162 20 127
WARFARIN SODIUM 196 179 21 15
FLUOXETINE HCL 186 103 22 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 184 113 23 24
ALLOPURINOL 178 139 24 36
NAMENDA 178 159 24 42
ISOSORBIDE MONONITRATE ER 174 161 26 34
ATORVASTATIN CALCIUM 172 122 27 13
DOXYCYCLINE HYCLATE 164 103 28 128
NIASPAN 164 111 28 125
LANTUS SOLOSTAR 163 85 30 129
LANTUS 161 136 31 49
PRAVASTATIN SODIUM 160 108 32 12
DOXAZOSIN MESYLATE 159 126 33 92
SERTRALINE HCL 156 101 34 20
SULFAMETHOXAZOLE-TRIMETHOPRIM 155 122 35 88
FENOFIBRATE 155 71 35 67
RISPERIDONE 154 111 37 79
PREDNISONE 153 81 38 40
JANUVIA 149 114 39 60
MIRTAZAPINE 143 94 40 61
METOPROLOL SUCCINATE 141 105 41 16
POLYETHYLENE GLYCOL 3350 136 113 42 46
PHENYTOIN SODIUM EXTENDED 133 70 43 147
DONEPEZIL HCL 129 129 44 32
NEXIUM 128 64 45 18
PAROXETINE HCL 123 76 46 45
CRESTOR 120 120 47 23
GLYBURIDE 118 75 R 48 68
LOSARTAN POTASSIUM 115 86 49 29
PEN NEEDLE 115 67 49 192
GLIMEPIRIDE 113 97 51 43
METOPROLOL TARTRATE 113 66 51 10
CLOPIDOGREL 111 92 53 28
CYCLOBENZAPRINE HCL 108 33 R 54 56
PROAIR HFA 108 45 54 37
AMLODIPINE BESYLATE-BENAZEPRIL 107 89 56 77
CLOZAPINE 101 0 57 318
DICLOFENAC SODIUM 100 29 58 74
DIGOXIN 100 97 58 52
GLIPIZIDE 99 75 60 64
VENTOLIN HFA 96 46 61 97
CLONIDINE HCL 95 61 62 53
CYMBALTA 95 49 62 50
RAMIPRIL 94 48 64 84
RANITIDINE HCL 94 69 64 21
DIVALPROEX SODIUM ER 92 34 66 216
OLANZAPINE 91 37 67 176
ZOLPIDEM TARTRATE 90 52 68 22
FINASTERIDE 89 87 69 130
DIOVAN 89 83 69 51
AMITRIPTYLINE HCL 88 53 R 71 48
INSULIN SYRINGE 87 66 72 78
METHOCARBAMOL 86 22 R 73 142
NABUMETONE 84 40 74 181
PLAVIX 82 69 75 39
QUETIAPINE FUMARATE 81 36 76 94
AMOXICILLIN 80 38 77 90
TRIAMCINOLONE ACETONIDE 78 45 78 137
SPIRONOLACTONE 78 65 78 72
CEFUROXIME 77 43 80 157
DIVALPROEX SODIUM 77 45 80 96
SYMBICORT 76 48 82 124
TAMSULOSIN HCL 75 70 83 30
KLOR-CON 10 75 72 83 143
ESCITALOPRAM OXALATE 74 59 85 82
BUSPIRONE HCL 71 27 86 107
NAPROXEN 71 33 86 80
ROPINIROLE HCL 70 60 88 69
DILTIAZEM ER 67 63 89 139
METOCLOPRAMIDE HCL 67 30 89 116
VYTORIN 65 34 91 169
NAPROXEN SODIUM 65 0 91 381
HYDROXYZINE HCL 62 23 R 93 162
NITROGLYCERIN PATCH 62 61 93 184
HYDRALAZINE HCL 62 58 93 99
DOXEPIN HCL 62 28 93 180
MEGESTROL ACETATE 61 47 R 97 178
GLIPIZIDE XL 61 49 97 166
AGGRENOX 60 59 99 243
IBUPROFEN 60 34 99 63
ACTOS 60 31 99 132
ATENOLOL-CHLORTHALIDONE 59 41 102 189
HUMALOG 57 32 103 226
LEVOFLOXACIN 56 36 104 71
NYSTATIN 56 46 104 110
CIPROFLOXACIN HCL 55 39 106 59
NOVOLOG FLEXPEN 55 31 106 230
SINGULAIR 54 18 108 65
SPIRIVA 54 40 108 57
ESTRADIOL 54 0 R 108 151
BENZTROPINE MESYLATE 54 24 R 108 174
LOSARTAN-HYDROCHLOROTHIAZIDE 51 42 112 66
VENLAFAXINE HCL ER 51 19 112 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.